comparemela.com

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus

Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a 'diSArm' Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,American ,Joyce Allaire ,Mina Pastagia ,Pierre Kyme ,Deborah Birx ,Defense Health Agency ,Naval Medical Research ,Data Review Committee ,Department Of Defense ,Armata Pharmaceuticals Inc ,Lifesci Advisors ,Us Department Of Defense ,Technology Enterprise Consortium ,Warfighter Medical Research Program ,Prnewswire Armata Pharmaceuticals Inc ,Chief Executive Officer ,Chief Medical Officer ,Medical Technology Enterprise Consortium ,Naval Medical Research Command ,Joint Warfighter Medical Research ,Armata Pharmaceuticals ,Private Securities Litigation Reform Act ,Annual Report ,Sci Advisors ,

comparemela.com © 2020. All Rights Reserved.